Is VOR undervalued or overvalued?
As of 2025-03-19, the Intrinsic Value of Vor Biopharma Inc (VOR) is -4.51 USD. This VOR valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.83 USD, the upside of Vor Biopharma Inc is -645.25%. This means that VOR is overvalued by 645.25%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -4.51 - -4.51 | -4.51 | -645.25% |
| P/E | (13.54) - (20.95) | (14.38) | -1839.3% |
| DDM - Stable | (8.83) - (29.70) | (19.26) | -2430.7% |
| DDM - Multi | (1.72) - (4.46) | (2.48) | -399.8% |
| Market Cap (mil) | 103.13 |
| Beta | 1.48 |
| Outstanding shares (mil) | 124.78 |
| Enterprise Value (mil) | 50.33 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.94% |
| Cost of Debt | 5.00% |
| WACC | 6.30% |